Award NoticeAwarded

Food and Drug Administration (FDA) Office of Clinical Pharmacology (OCP) Multi-phase/Multi- site Clinical Studies and Laboratory Support Indefinite Delivery-Indefinite Quantity (IDIQ) Type Contract

HEALTH AND HUMAN SERVICES, DEPARTMENT OF · FDA OFFICE OF ACQ GRANT SVCS

This notice records an award. Find active opportunities

Award Information

This solicitation resulted in an award to TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC Webster TX 77598 USA for approximately $50,000,000 on September 15, 2025. Similar contracts are typically issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF under 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Award Number: 75F40125D00003
Award Amount: $50,000,000
Award Date: September 15, 2025
Awardee: TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC Webster TX 77598 USA

View full award details on USASpending.gov

Contract Details

Notice ID: 75F40124R00064
Opportunity Type: Award Notice
Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-Agency: FOOD AND DRUG ADMINISTRATION
Office: FDA OFFICE OF ACQ GRANT SVCS
Posted Date: Tuesday, September 16, 2025
Response Deadline: Not specified
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC Code: AJ12
Set-Aside: Small Business
Place of Performance: TX, 77598, USA
Status: Awarded

View on SAM.gov

Description

This is a commercial services Food and Drug Administration (FDA) open market single-award Indefinite Delivery-Indefinite Quantity (IDIQ) type contract set aside 100% for small business. The scope of activities FDA may require of the contractor shall include the capability to conduct multiple Phase I clinical trials within a year and at times in parallel, and the provision of a full range of services to support the clinical trials and reporting of the results. The Authorized Task Order (TO) type under this IDIQ contract is Firm-Fixed-Price (FFP).